Biotechnology

432 readers
8 users here now

Biology and technology to tackle the issues of the 21st century.

founded 3 years ago
MODERATORS
1
2
3
4
5
6
7
 
 

cross-posted from: https://slrpnk.net/post/27540238

  • With Bangladesh’s growing economy and city dwellers’ purchasing capacity, the tendency to gather for parties and serve food has also increased in the country.
  • With concerns for environmental protections, many of them are choosing biodegradable tableware instead of single-use plastic.
  • A few local entrepreneurs are now producing tableware like plates and straws from biodegradable and locally available materials like areca leaves for plates and rice bran and jute for straws.
  • However, entrepreneurs are struggling with production costs and are looking forward to the policy support that industries producing environment-friendly products usually receive in Bangladesh.

archived (Wayback Machine)

8
 
 

cross-posted from: https://slrpnk.net/post/27540124

  • Recently, Bangladesh successfully developed lotus silk — a biodegradable luxury fabric — using lotus stems, merging ancient tradition with modern sustainability science.
  • Unlike conventional textiles, lotus silk is produced without water, chemicals or fossil fuels — making it one of the most eco-friendly fabrics in the world today.
  • With high prices, lotus silk is attracting top fashion houses internationally, giving Bangladesh an opportunity to gain a premium place in the ethical fashion market.
  • In some villages, lotus silk is creating new jobs for women who are now skilled in producing this high-value, global product; it’s reviving Bangladesh’s artisanal legacy.

archived (Wayback Machine)

9
10
 
 

A paralysed man can stand on his own after receiving an injection of neural stem cells to treat his spinal cord injury. The Japanese man was one of four individuals in a first-of-its-kind trial that used reprogrammed stem cells to treat people who are fully paralysed.

Another man can now move his arms and legs following the treatment, but the two others did not show substantial improvements. The trial was run by Hideyuki Okano, a stem-cell scientist at Keio University in Tokyo, and his colleagues.

11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
view more: next ›